190 related articles for article (PubMed ID: 10441019)
1. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.
Kvistad KA; Bakken IJ; Gribbestad IS; Ehrnholm B; Lundgren S; Fjøsne HE; Haraldseth O
J Magn Reson Imaging; 1999 Aug; 10(2):159-64. PubMed ID: 10441019
[TBL] [Abstract][Full Text] [Related]
2. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
3. Human breast lesions: characterization with proton MR spectroscopy.
Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
[TBL] [Abstract][Full Text] [Related]
4. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
5. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.
Gribbestad IS; Singstad TE; Nilsen G; Fjøsne HE; Engan T; Haugen OA; Rinck PA
J Magn Reson Imaging; 1998; 8(6):1191-7. PubMed ID: 9848727
[TBL] [Abstract][Full Text] [Related]
6. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
7. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.
Stanwell P; Gluch L; Clark D; Tomanek B; Baker L; Giuffrè B; Lean C; Malycha P; Mountford C
Eur Radiol; 2005 May; 15(5):1037-43. PubMed ID: 15351906
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
10. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
Bolan PJ; Meisamy S; Baker EH; Lin J; Emory T; Nelson M; Everson LI; Yee D; Garwood M
Magn Reson Med; 2003 Dec; 50(6):1134-43. PubMed ID: 14648561
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
[TBL] [Abstract][Full Text] [Related]
12. Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo
Agarwal K; Sharma U; Mathur S; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2018 Jun; 49():116-122. PubMed ID: 29454110
[TBL] [Abstract][Full Text] [Related]
13. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results.
Yeung DK; Cheung HS; Tse GM
Radiology; 2001 Jul; 220(1):40-6. PubMed ID: 11425970
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.
Thakur SB; Brennan SB; Ishill NM; Morris EA; Liberman L; Dershaw DD; Bartella L; Koutcher JA; Huang W
J Magn Reson Imaging; 2011 Apr; 33(4):855-63. PubMed ID: 21448950
[TBL] [Abstract][Full Text] [Related]
15. Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.
Thakur SB; Horvat JV; Hancu I; Sutton OM; Bernard-Davila B; Weber M; Oh JH; Marino MA; Avendano D; Leithner D; Brennan S; Giri D; Manderski E; Morris EA; Pinker K
J Magn Reson Imaging; 2019 Jul; 50(1):239-249. PubMed ID: 30605266
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
Shin HJ; Baek HM; Cha JH; Kim HH
AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
[TBL] [Abstract][Full Text] [Related]
17. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
[TBL] [Abstract][Full Text] [Related]
19. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast.
Lenkinski RE; Wang X; Elian M; Goldberg SN
Magn Reson Med; 2009 Jun; 61(6):1286-92. PubMed ID: 19365855
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
